These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 8313378)

  • 1. DNA damage increases the levels of MDM2 messenger RNA in wtp53 human cells.
    Price BD; Park SJ
    Cancer Res; 1994 Feb; 54(4):896-9. PubMed ID: 8313378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells.
    Gudas JM; Nguyen H; Klein RC; Katayose D; Seth P; Cowan KH
    Clin Cancer Res; 1995 Jan; 1(1):71-80. PubMed ID: 9815889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of a gene encoding a p53-associated protein in human sarcomas.
    Oliner JD; Kinzler KW; Meltzer PS; George DL; Vogelstein B
    Nature; 1992 Jul; 358(6381):80-3. PubMed ID: 1614537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Wild type p53 can mediate sequence-specific transactivation of an internal promoter within the mdm2 gene.
    Juven T; Barak Y; Zauberman A; George DL; Oren M
    Oncogene; 1993 Dec; 8(12):3411-6. PubMed ID: 8247544
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The p53 mRNA-Mdm2 interaction controls Mdm2 nuclear trafficking and is required for p53 activation following DNA damage.
    Gajjar M; Candeias MM; Malbert-Colas L; Mazars A; Fujita J; Olivares-Illana V; Fåhraeus R
    Cancer Cell; 2012 Jan; 21(1):25-35. PubMed ID: 22264786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
    Chen CY; Oliner JD; Zhan Q; Fornace AJ; Vogelstein B; Kastan MB
    Proc Natl Acad Sci U S A; 1994 Mar; 91(7):2684-8. PubMed ID: 8146175
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mdm2: keeping p53 under control.
    Piette J; Neel H; Maréchal V
    Oncogene; 1997 Aug; 15(9):1001-10. PubMed ID: 9285554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The high levels of p53 present in adenovirus early region 1-transformed human cells do not cause up-regulation of MDM2 expression.
    Grand RJ; Lecane PS; Owen D; Grant ML; Roberts S; Levine AJ; Gallimore PH
    Virology; 1995 Jul; 210(2):323-34. PubMed ID: 7618270
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wild-type p53 protein is unable to activate the mdm-2 gene during F9 cell differentiation.
    Mayo LD; Berberich SJ
    Oncogene; 1996 Dec; 13(11):2315-21. PubMed ID: 8957072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Defects in transcription coupled repair interfere with expression of p90(MDM2) in response to ultraviolet light.
    Michalowski J; Seavey SE; Mendrysa SM; Perry ME
    Oncogene; 2001 Sep; 20(41):5856-64. PubMed ID: 11593391
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationships between G1 arrest and stability of the p53 and p21Cip1/Waf1 proteins following gamma-irradiation of human lymphoma cells.
    Bae I; Fan S; Bhatia K; Kohn KW; Fornace AJ; O'Connor PM
    Cancer Res; 1995 Jun; 55(11):2387-93. PubMed ID: 7757991
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HDMX folds the nascent p53 mRNA following activation by the ATM kinase.
    Malbert-Colas L; Ponnuswamy A; Olivares-Illana V; Tournillon AS; Naski N; Fåhraeus R
    Mol Cell; 2014 May; 54(3):500-11. PubMed ID: 24813712
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DNA-damaging aryl hydrocarbons induce Mdm2 expression via p53-independent post-transcriptional mechanisms.
    Hsing A; Faller DV; Vaziri C
    J Biol Chem; 2000 Aug; 275(34):26024-31. PubMed ID: 10856296
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations.
    Reifenberger G; Liu L; Ichimura K; Schmidt EE; Collins VP
    Cancer Res; 1993 Jun; 53(12):2736-9. PubMed ID: 8504413
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective compartmentalization of different mdm2 proteins within the nucleus.
    Maxwell SA
    Anticancer Res; 1994; 14(6B):2541-7. PubMed ID: 7872679
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA binding activities of p53 protein following cisplatin damage of ovarian cells.
    Wetzel CC; Berberich SJ
    Oncol Res; 1998; 10(3):151-61. PubMed ID: 9700726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transfection with mdm2-antisense or wtp53 results in radiosensitization and an increased apoptosis of a soft tissue sarcoma cell line.
    Grünbaum U; Meye A; Bache M; Bartel F; Würl P; Schmidt H; Dunst J; Taubert H
    Anticancer Res; 2001; 21(3B):2065-71. PubMed ID: 11497299
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced translation: a novel mechanism of mdm2 oncogene overexpression identified in human tumor cells.
    Landers JE; Haines DS; Strauss JF; George DL
    Oncogene; 1994 Sep; 9(9):2745-50. PubMed ID: 8058341
    [TBL] [Abstract][Full Text] [Related]  

  • 19. mdm2 expression is induced by wild type p53 activity.
    Barak Y; Juven T; Haffner R; Oren M
    EMBO J; 1993 Feb; 12(2):461-8. PubMed ID: 8440237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53 and mdm2 are expressed independently during cellular proliferation.
    Mosner J; Deppert W
    Oncogene; 1994 Nov; 9(11):3321-8. PubMed ID: 7936657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.